Drawing for PROTEOGENIX

USPTO serial 79406602

PROTEOGENIX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
KELLY, JOHN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with PROTEOGENIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard A. Castellano

Richard A. Castellano CASTELLANO PLLC1250 Connecticut Ave, NW700Washington, DC 20036

Goods and services

ClassDescriptionStatusFirst use
042Scientific and technological research in the fields of molecular biology, immunology, biotechnology, and diagnostics for others; research and development in the field of therapeutic antibodies and proteins for others; biology services for research purposes, namely, biomedical research laboratory services; protein and antibody engineering; protein and antibody engineering, namely, antibody humanization, affinity maturation and optimization services; gene synthesis and peptide synthesis, namely, laboratory services for biomanufacturing genes and peptides; research and development services in molecular and cellular biology; research and development services in immunology, namely, antibody discovery services, phage display library screening services, single B-cell screening, hybridoma development and epitope mappingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 6, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 6, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 1, 2026GPNXNOTIFICATION PROCESSED BY IB—
Sep 30, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 16, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 16, 2026OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 5, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 3, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 2, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 2, 2026ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 10, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 10, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 10, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 26, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 20, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 20, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 20, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 9, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 9, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 5, 2026GAUNNOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED—
Mar 5, 2026GAUDNOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED—
Mar 5, 2026NAUDREPORT UNRESPONSIVE AMENDMENT - COMPLETED—
Nov 8, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 7, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 7, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 5, 2025RFNTREFUSAL PROCESSED BY IB—
Aug 15, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 14, 2025RFRRREFUSAL PROCESSED BY MPU—
May 3, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 2, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 28, 2025DOCKASSIGNED TO EXAMINER—
Oct 16, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 16, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 10, 2024SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance